DISON I - Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis (DISON I)
2026年8月2日 更新者:Ventaris Surgical Incorporated
DISON I - Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis- A Multicenter Prospective Pilot Study
A single-arm, multicenter, international, prospective interventional study designed to evaluate the safety and performance of an investigational device during retrograde intrarenal surgery for the treatment of renal calculi.
研究概览
研究类型
介入性
注册 (估计的)
75
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习联系方式
- 姓名:Matt Sprinkel
- 电话号码:+1 650 465 6200
- 邮箱:matt@ventarissurgical.com
学习地点
-
-
-
Montreal、加拿大
- Centre hospitalier de l'Université de Montréal (CHUM)
-
接触:
- Research Coordinator
- 电话号码:22931 514-890-8000
- 邮箱:abbas.guennoun.chum@ssss.gouv.qc.ca
-
-
-
-
-
Nadiād、印度
- Muljibhai Patel Urological Hospital
-
接触:
- Research Coordinator
- 电话号码:912682520328
- 邮箱:monil.parmar@mpuh.in
-
-
-
-
-
Tauranga、新西兰
- Tauranga Urology Research Limited
-
接触:
- Research Coordinator
- 电话号码:(07) 579 0466
- 邮箱:marg@urobop.co.nz
-
-
-
-
-
Buenos Aires、阿根廷
- Hospital Aleman
-
接触:
- Head of Clinical Investigations
- 电话号码:2286/ 7039 (011) 4827 7000
- 邮箱:pperez@hospitalaleman.com
-
-
-
-
-
Hong Kong、香港
- The Chinese University of Hong Kong
-
接触:
- Research Coordinator
- 电话号码:3505 2211
- 邮箱:francolai@surgery.cuhk.edu.hk
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- Diagnosis of calyceal and/or renal pelvis calculi
- Age from 18 through 85 years
- Maximum stone diameter between 0.5cm - 2.0cm as assessed by Non-Contrast CT scan (≤ 2 mm slice thickness) within 90 days prior to treatment
- Willing and able to comply with all study requirements
- Signs study-specific informed consent form
Exclusion Criteria:
- Diagnosis of calculus of the ureter
- BMI ≥ 42
- Significant renal impairment: stage 3a CKD or higher (eGFR <59mL/min)
- Active infection, including urinary tract infection
- Urological anatomic/congenital abnormalities
- Previous history of struvite stone in the same renal unit
- Taking anticoagulants that cannot be stopped before and after procedure or known coagulopathy or platelet disorder (except aspirin below 100mg/d)
- History of gross hematuria
- Solitary functioning kidney
- Known allergy to device materials
- Any severe illness that would prevent complete study participation or confound study results
- Serious concurrent medical conditions such as heart disease (e.g., myocardial infarction within 30 days, congestive heart failure - NYHA Class IV), pulmonary disease or uncontrolled diabetes.
- History of open-heart surgery, or cardiac arrest < 180 days prior to the date of informed consent
- ASA III or higher
- Taking systemic immune suppressants
- Dementia or psychiatric condition that prevents the participant from completing required follow up
- Contraindication to both general and spinal anesthesia
- Participating in another investigational study that could affect responses to the study device
- Unwilling to accept a transfusion should one be required
- Pregnant or considering getting pregnant within the next 3 months
- Undergoing bilateral ureteroscopy
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Investigational endourological device used during retrograde intrarenal surgery.
|
Investigational endourological device used during retrograde intrarenal surgery.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Procedure success
大体时间:Intraoperative
|
Successful completion of the planned procedure without device-related technical complications.
|
Intraoperative
|
|
Stone-Free Status
大体时间:30 days post-procedure
|
Absence of residual stone fragments on CT imaging
|
30 days post-procedure
|
|
Serious Adverse Device Effects (SADEs)
大体时间:30 days post-procedure
|
Serious adverse device effects related to the investigational device.
|
30 days post-procedure
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Stone-Free Categories
大体时间:30 days post-procedure
|
Stone-free status according to predefined categories.
|
30 days post-procedure
|
|
Intrarenal pressure assessment
大体时间:Intraoperative
|
Intrarenal pressure measured during the procedure.
|
Intraoperative
|
|
Procedure duration
大体时间:Intraoperative
|
Duration of the surgical procedure.
|
Intraoperative
|
|
Stone clearance
大体时间:Intraoperative
|
Amount of stone material removed during the procedure.
|
Intraoperative
|
|
Residual stone burden
大体时间:30 days post-procedure
|
Residual stone burden assessed by imaging.
|
30 days post-procedure
|
|
Device- or procedure-related adverse event
大体时间:From procedure to 12 months post-procedure
|
Device- or procedure-related adverse event.
|
From procedure to 12 months post-procedure
|
|
Stone-related healthcare utilization
大体时间:From procedure to 12 months post-procedure
|
Healthcare utilization related to recurrent stone symptoms in the treated kidney.
|
From procedure to 12 months post-procedure
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
2026年10月1日
初级完成 (估计的)
2028年8月1日
研究完成 (估计的)
2028年8月1日
研究注册日期
首次提交
2026年7月11日
首先提交符合 QC 标准的
2026年7月11日
首次发布 (实际的)
2026年7月20日
研究记录更新
最后更新发布 (实际的)
2026年8月5日
上次提交的符合 QC 标准的更新
2026年8月2日
最后验证
2026年7月1日
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- VS-0001
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
不
IPD 计划说明
IPD will not be shared because this is an early feasibility study involving a small cohort of participants.
The data set is limited and may contain information that could risk re-identification.
Summary results and aggregate findings will be published following study completion.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
是的
在美国制造并从美国出口的产品
是的
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.